PV
Palvella Therapeutics, Inc. (PVLA)
NASDAQ·Healthcare·Biotechnology
$143.96
+0.71%
Mkt Cap $1.68B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (33 analysts)
$232.00
Range $210.00 – $270.00
Implied Upside
+61.2%
Consensus $232.00 vs current $143.96